Yasuo Urata Selected Research

Adenocarcinoma of Lung

5/2018

Clinical features of squamous cell lung cancer with anaplastic lymphoma kinase (ALK)-rearrangement: a retrospective analysis and review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuo Urata Research Topics

Disease

62	Neoplasms (Cancer) 06/2024 - 09/2004
11	Infections 06/2022 - 04/2005
7	Osteosarcoma (Osteogenic Sarcoma) 05/2021 - 06/2011
6	Neoplasm Metastasis (Metastasis) 06/2022 - 03/2015
6	Circulating Neoplastic Cells 05/2018 - 10/2009
5	Sarcoma (Soft Tissue Sarcoma) 04/2024 - 04/2011
5	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 10/2022
5	Stomach Neoplasms (Stomach Cancer) 06/2022 - 01/2016
4	Lung Neoplasms (Lung Cancer) 05/2018 - 02/2006
4	Lymphatic Metastasis 03/2015 - 10/2006
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2017 - 02/2006
3	Virus Diseases (Viral Diseases) 12/2011 - 04/2011
2	Adenocarcinoma 05/2023 - 12/2022
2	Squamous Cell Carcinoma of Head and Neck 12/2022 - 03/2014
2	Rectal Neoplasms (Rectal Cancer) 10/2021 - 03/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 06/2010
2	Melanoma (Melanoma, Malignant) 08/2017 - 04/2016
2	Triple Negative Breast Neoplasms 01/2017 - 12/2016
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 03/2015
2	Head and Neck Neoplasms (Head and Neck Cancer) 04/2009 - 01/2009
2	Carcinogenesis 01/2008 - 03/2007
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Esophageal Neoplasms (Esophageal Cancer) 04/2022
1	Vomiting 01/2022
1	Anemia 01/2022
1	Fatigue 01/2022
1	Hypertriglyceridemia 01/2022
1	Abdominal Pain (Pain, Abdominal) 01/2022
1	Surgical Wound 12/2020
1	Fibrosis (Cirrhosis) 12/2020
1	Glaucoma 12/2020
1	Blister (Bulla) 12/2020
1	Neuroblastoma 09/2020
1	Adenocarcinoma of Lung 05/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018
1	Carcinoma (Carcinomatosis) 11/2017
1	Peritonitis 11/2017
1	Ascites 11/2017
1	Leukemia 09/2017
1	Breast Neoplasms (Breast Cancer) 08/2016

Drug/Important Bio-Agent (IBA)

57	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2024 - 09/2004
13	Green Fluorescent ProteinsIBA 01/2024 - 09/2004
8	Proteins (Proteins, Gene)FDA Link 05/2023 - 11/2010
6	Indicators and Reagents (Reagents)IBA 04/2024 - 04/2011
6	adenovirus receptorIBA 01/2024 - 04/2005
5	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 01/2016
5	Methylnitronitrosoguanidine (MNNG)IBA 01/2021 - 04/2011
4	Immune Checkpoint InhibitorsIBA 06/2024 - 05/2021
4	Adenosine Triphosphate (ATP)IBA 02/2024 - 05/2012
4	DNA (Deoxyribonucleic Acid)IBA 05/2018 - 06/2009
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 10/2009
4	Red Fluorescent ProteinIBA 12/2016 - 01/2015
4	ElementsIBA 02/2009 - 09/2004
3	Messenger RNA (mRNA)IBA 12/2013 - 04/2011
2	Therapeutic UsesIBA 10/2023 - 10/2021
2	Gemcitabine FDA Link 05/2023 - 04/2009
2	Histone Deacetylase InhibitorsIBA 01/2022 - 02/2006
2	YM753 compoundIBA 01/2022 - 12/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2016
2	Estrogens (Estrogen)FDA Link 01/2017 - 12/2016
2	Progesterone FDA LinkGeneric 01/2017 - 12/2016
2	Internal Ribosome Entry SitesIBA 02/2006 - 09/2004
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 02/2024
1	EnzymesIBA 01/2024
1	LigandsIBA 05/2023
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2023
1	CytokinesIBA 06/2022
1	Interleukin-6 (Interleukin 6)IBA 06/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	TransferasesIBA 01/2022
1	DepsipeptidesIBA 01/2022
1	Ophthalmic Solutions (Eye Drops)IBA 12/2020
1	CollagenIBA 12/2020
1	HMGB1 Protein (HMG1)IBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 05/2018
1	Keratins (Keratin)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Epithelial Cell Adhesion MoleculeIBA 05/2017
1	NestinIBA 03/2017
1	Neutralizing AntibodiesIBA 11/2016
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2016

Therapy/Procedure

22	Therapeutics 04/2024 - 04/2005
10	Oncolytic Virotherapy 04/2024 - 03/2007
7	Drug Therapy (Chemotherapy) 06/2022 - 01/2016
4	Radiotherapy 12/2022 - 01/2012
3	Injections 01/2023 - 11/2009
3	Aftercare (After-Treatment) 11/2017 - 03/2015
3	Transplantation 11/2017 - 08/2016
3	Lasers (Laser) 08/2017 - 01/2016
3	Computer-Assisted Surgery (Image Guided Surgery) 08/2011 - 10/2006
2	Immunotherapy 06/2024 - 05/2021
2	Combined Modality Therapy 10/2022 - 06/2010
2	Chemoradiotherapy 12/2013 - 01/2012
2	Laparotomy 01/2008 - 10/2006
1	Intravenous Infusions 01/2022
1	Filtering Surgery 12/2020
1	Precision Medicine 10/2018
1	Stents 01/2018
1	Biological Therapy 11/2016